Cargando…
Trends of ARNI and Other Heart Failure Medication Use in Older Adults
In 2015-2017, we identified 276,679 to 315,788 Medicare beneficiaries with HFrEF (mean age 76.6-76.7 years, 75.0-76.2% male, 82.0-83.4% Whites, and 44.8-50.9% frail). Since its approval in July 2015, ARNI use increased from 0.3% to 5.7%. ARNI uptake was lower in patients with older age (6.6% for 65-...
Autores principales: | Lee, Yu-Chien, Patorno, Elisabetta, Gopalakrishnan, Chandrasekar, Kim, Dae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8682473/ http://dx.doi.org/10.1093/geroni/igab046.805 |
Ejemplares similares
-
Monitoring the Effectiveness and Safety of ARNI vs. Angiotensin Receptor Blocker by Frailty Status
por: Kim, Dae, et al.
Publicado: (2021) -
UTILIZATION TRENDS OF GLUCOSE-LOWERING DRUGS FOR TYPE 2 DIABETES IN OLDER ADULTS WITH AND WITHOUT DEMENTIA
por: Gopalakrishnan, Chandrasekar, et al.
Publicado: (2022) -
Monitoring Utilization Trends of Glucose-Lowering Drugs for Type 2 Diabetes in Older Adults by Frailty Status
por: Gopalakrishnan, Chandrasekar, et al.
Publicado: (2021) -
Monitoring the Comparative Safety of SGLT2i vs GLP-1 RA in Older Adults With Type 2 Diabetes by Frailty Status
por: Kutz, Alexander, et al.
Publicado: (2021) -
Prospective Monitoring of Newly Marketed Drugs in Frail Older Adults Using Real-World Databases
por: Kim, Dae, et al.
Publicado: (2021)